CN105263474A - 皮质类固醇组合物 - Google Patents

皮质类固醇组合物 Download PDF

Info

Publication number
CN105263474A
CN105263474A CN201480031734.4A CN201480031734A CN105263474A CN 105263474 A CN105263474 A CN 105263474A CN 201480031734 A CN201480031734 A CN 201480031734A CN 105263474 A CN105263474 A CN 105263474A
Authority
CN
China
Prior art keywords
propylene glycol
glyceryl
acetate
hydrocortisone
glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480031734.4A
Other languages
English (en)
Chinese (zh)
Inventor
R·兰瑟罗普
D·W·奥斯伯尔尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tolmar Inc
Original Assignee
Tolmar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tolmar Inc filed Critical Tolmar Inc
Publication of CN105263474A publication Critical patent/CN105263474A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN201480031734.4A 2013-06-03 2014-06-02 皮质类固醇组合物 Pending CN105263474A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361830531P 2013-06-03 2013-06-03
US61/830,531 2013-06-03
PCT/US2014/040560 WO2014197398A1 (en) 2013-06-03 2014-06-02 Corticosteroid compositions

Publications (1)

Publication Number Publication Date
CN105263474A true CN105263474A (zh) 2016-01-20

Family

ID=51014660

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480031734.4A Pending CN105263474A (zh) 2013-06-03 2014-06-02 皮质类固醇组合物

Country Status (9)

Country Link
EP (1) EP3003272A1 (https=)
JP (1) JP2016520656A (https=)
CN (1) CN105263474A (https=)
AR (1) AR096459A1 (https=)
AU (1) AU2014275195A1 (https=)
CA (1) CA2912873A1 (https=)
HK (1) HK1223300A1 (https=)
MX (1) MX2015016603A (https=)
WO (1) WO2014197398A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108348426A (zh) * 2015-09-08 2018-07-31 诺瓦蒙特股份公司 含壬酸酯的水性化妆品组合物

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2637447T3 (es) 2009-08-31 2017-10-13 Dr. Reddy's Laboratories Ltd. Formulaciones tópicas que contienen un esteroide
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
BR112020010519A2 (pt) * 2017-11-27 2020-10-20 Umecrine Cognition Ab formulação farmacêutica de oxima de 3¿lfa-etinil-3¿eta-hidroxiandrostan-17-ona
WO2023277616A1 (ko) * 2021-06-30 2023-01-05 주식회사 디네이쳐 중대가리풀 유래의 추출물을 포함하는 탈모기능성 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1048820A (en) * 1963-05-29 1966-11-23 Merck & Co Inc Emollient compositions containing liquid fatty acid esters
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
JP3471840B2 (ja) * 1993-03-04 2003-12-02 日本ワイスレダリー株式会社 外用剤
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
GB9618964D0 (en) * 1996-09-11 1996-10-23 Tillotts Pharma Ag Oral composition
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
MXPA01013460A (es) * 1999-06-25 2003-09-04 Durham Pharmaceuticals Ltd Formulaciones topicas que comprenden agentes de penetracion de la piel y uso de las mismas.
JP2001233772A (ja) * 2000-02-23 2001-08-28 Taiho Yakuhin Kogyo Kk 外用剤組成物
KR100433614B1 (ko) * 2000-06-16 2004-05-31 주식회사 태평양 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제
PL1648412T3 (pl) * 2003-07-07 2008-04-30 Nares Ab Mikroemulsje i ich zastosowanie do zapobiegania chorobom dróg oddechowych
EP1744760B1 (en) * 2004-04-22 2015-01-07 AcuCort AB Pharmaceutical compositions for acute glucocorticoid therapy
CA2591296A1 (en) * 2004-12-09 2006-06-15 Bayer Healthcare Ag Stabilisation of glucocorticoid esters with acids
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
FR2889662B1 (fr) * 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
GB2445539A (en) * 2006-12-29 2008-07-16 Ardana Bioscience Ltd Bigel composition
US20090181068A1 (en) 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
AU2011264198B2 (en) * 2010-06-11 2015-04-09 Leo Pharma A/S A pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
WO2013076160A1 (en) * 2011-11-21 2013-05-30 Université Libre de Bruxelles Sustained release formulations useful in the treatment of diseases
CN102940594A (zh) * 2012-12-04 2013-02-27 艾能赛克机械设备(江苏)有限公司 一种头发调理剂

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108348426A (zh) * 2015-09-08 2018-07-31 诺瓦蒙特股份公司 含壬酸酯的水性化妆品组合物
CN108348426B (zh) * 2015-09-08 2021-10-15 诺瓦蒙特股份公司 含壬酸酯的水性化妆品组合物

Also Published As

Publication number Publication date
MX2015016603A (es) 2016-07-28
JP2016520656A (ja) 2016-07-14
WO2014197398A1 (en) 2014-12-11
AU2014275195A1 (en) 2015-12-10
EP3003272A1 (en) 2016-04-13
HK1223300A1 (zh) 2017-07-28
CA2912873A1 (en) 2014-12-11
AR096459A1 (es) 2015-12-30

Similar Documents

Publication Publication Date Title
US10111956B2 (en) Corticosteroid compositions
JP5833007B2 (ja) ステロイドを含む局所製剤
AU2015385750B2 (en) Topical corticosteroid compositions
US11179465B2 (en) Topical compositions comprising a corticosteroid
CN105263474A (zh) 皮质类固醇组合物
EP3049063A1 (en) Topical spray composition of halobetasol

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160120

WD01 Invention patent application deemed withdrawn after publication